Graversen Peter Laursen, Østergaard Lauge, Voldstedlund Marianne, Wandall-Holm Malthe Faurschou, Smerup Morten Holdgaard, Køber Lars, Fosbøl Emil Loldrup
Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Data Integration and Analysis, Statens Serum Institut, 2300 Copenhagen, Denmark.
Microorganisms. 2023 Sep 26;11(10):2403. doi: 10.3390/microorganisms11102403.
Microbiological etiology has been associated with surgery for infective endocarditis (IE) during admission, especially . We aimed to compare patient characteristics, microbiological characteristics, and outcomes by treatment choice (surgery or not). We identified patients with first-time IE between 2010 and 2020 and examined the microbiological etiology of IE according to treatment choice. To identify factors associated with surgery during initial admission, we used the Aalen-Johansen estimator and an adjusted cause-specific Cox model. One-year mortality stratified by microbiological etiology and treatment choice was assessed using unadjusted Kaplan-Meier estimates and an adjusted Cox proportional hazard model. A total of 6255 patients were included, of which 1276 (20.4%) underwent surgery during admission. Patients who underwent surgery were younger (65 vs. 74 years) and less frequently had cerebrovascular disease, cardiovascular disease, diabetes, and chronic kidney disease. Patients with IE were less likely to undergo surgery during admission (13.6%) compared to all other microbiological etiologies. One-year mortality according to microbiological etiology in patients who underwent surgery was 7.0%, 5.3%, 5.5%, 9.6%, 13.2, and 11.2% compared with 24.2%, 19.1%, 27,6%, 25.2%, 21%, and 16.9% in patients who received medical therapy for , spp., spp., coagulase-negative Staphylococci, "other microbiological etiologies", and blood culture-negative infective endocarditis, respectively. Patients with IE who underwent surgery differed in terms of microbiology, more often having Streptococci than those who received medical therapy. Contrary to expectations, was more common among patients who received medical therapy only.
微生物病因与住院期间感染性心内膜炎(IE)的手术治疗有关,尤其是……我们旨在通过治疗选择(手术与否)比较患者特征、微生物特征和治疗结果。我们确定了2010年至2020年期间首次发生IE的患者,并根据治疗选择检查了IE的微生物病因。为了确定初次住院期间与手术相关的因素,我们使用了阿伦-约翰森估计量和调整后的特定病因Cox模型。使用未调整的Kaplan-Meier估计量和调整后的Cox比例风险模型评估按微生物病因和治疗选择分层的1年死亡率。共纳入6255例患者,其中1276例(20.4%)在住院期间接受了手术。接受手术的患者更年轻(65岁对74岁),患脑血管疾病、心血管疾病、糖尿病和慢性肾病的频率更低。与所有其他微生物病因相比,感染IE的患者在住院期间接受手术的可能性较小(13.6%)。接受手术的患者中,根据微生物病因的1年死亡率分别为7.0%、5.3%、5.5%、9.6%、13.2%和11.2%,而接受药物治疗的患者中,针对……菌属、……菌属、凝固酶阴性葡萄球菌、“其他微生物病因”和血培养阴性感染性心内膜炎的1年死亡率分别为24.2%、19.1%、27.6%、25.2%、21%和16.9%。接受手术的感染IE患者在微生物学方面存在差异,链球菌感染比接受药物治疗的患者更常见。与预期相反,……在仅接受药物治疗的患者中更为常见。